This inventor holds 2 USPTO granted patents and 2 EPO patents. Top assignee: Yamanouchi Pharmaceutical Company Ltd.. Active years: 1996-1998.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1996-1998
Title: Innovator Noboru Yamaji: Pioneering Developments in Human MACIF Activity
Introduction
Noboru Yamaji, an accomplished inventor based in Tokyo, Japan, has made significant contributions to the field of biotechnology through his innovative research and development. With a total of 2 patents to his name, Yamaji's work focuses on the intricate dynamics of proteins associated with human MACIF (Membrane Attack Complex Inhibition Factor) activity, enhancing our understanding of cellular mechanisms and potential therapeutic applications.
Latest Patents
Yamaji's latest patents showcase his dedication to advancing health science. One notable patent involves genes coding for a protein exhibiting human MACIF activity, along with expression vectors that contain these genes. This patent also encompasses transformed cells with the vectors and proteins that have human MACIF activity. Furthermore, another patent emphasizes a fusion protein combining the extracellular domain of the human MACIF gene product with a heterologous phosphatidylinositol (PI) anchor domain, thereby offering novel insights and applications in the field of membrane biology.
Career Highlights
Currently affiliated with Yamanouchi Pharmaceutical Company Ltd., Yamaji's work is pivotal in leading innovative projects that aim to address pressing medical challenges. His research not only contributes to the scientific community but also adds substantial value to the pharmaceutical industry by paving the way for new therapeutic strategies.
Collaborations
Throughout his career, Yamaji has collaborated with esteemed coworkers, including Motowo Tomita and Yuji Sugita. These collaborations have fostered a productive environment that encourages the exchange of ideas and techniques, ultimately enhancing the quality and impact of their research.
Conclusion
Noboru Yamaji stands out as a significant contributor to the biopharmaceutical landscape with his focus on human MACIF activity. His innovative patents reflect his commitment to advancing scientific knowledge and improving health outcomes. Through his work at Yamanouchi Pharmaceutical Company Ltd. and collaborations with other accomplished professionals, Yamaji continues to inspire future innovations in biotechnology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile